On this page of StockholderLetter.com we present the latest annual shareholder letter from LifeMD, Inc. — ticker symbol LFMD. Reading current and past LFMD letters to shareholders can bring important insights into the investment thesis.
LIFEMD, INC. 2023 ANNUAL REPORT LifeMD, Inc. Board of Directors and Executive Officers as of April 29, 2024 BOARD OF DIRECTORS Name Principal Occupation or Employment Justin Schreiber Chairman of the Board of Directors, LifeMD, Inc. Chief Executive Officer, LifeMD, Inc. Partner, Strawn Pickens LLP Clinical Professor of Surgery, New Jersey Medical School Former Senior Director, Blackstone Chief Financial Officer, Nostrella Operating Adviser, Ares Private Equity Group Senior Staff Physician, Boston Children s Hospital Chief Executive Officer and a Director, OptimizeRx Corporation Vice Chair for Scientific Innovation at the Department of Medicine at Brigham and Women s Hospital and Associate Professor of Medicine at Harvard Medical School John R. Strawn, Jr. Dr. Joseph V. DiTrolio, MD Naveen Bhatia Roberto Simon Robert Jindal Dr. Joan LaRovere, M.D. William Febbo 'U Calum MacRae, M.D., Ph.D. EXECUTIVE OFFICERS Name Principal Occupation or Employment Justin Schreiber Stefan Galluppi Marc Benathen Nicholas Alvarez Eric Yecies Jessica Friedeman Dennis Wijnker Maria Stan Shane Biffar Chief Executive Officer Chief Innovation Officer Chief Financial Officer Chief Acquisition Officer Chief Legal Officer and General Counsel Chief Marketing Officer Chief Technology Officer Controller and Chief Accounting Officer Chief Compliance Officer and Deputy General Counsel
 • shareholder letter icon 4/29/2024 Letter Continued (Full PDF)
 • stockholder letter icon 4/28/2023 LFMD Stockholder Letter
 • Benford's Law Stocks icon LFMD Benford's Law Stock Score = 90


LFMD Shareholder/Stockholder Letter Transcript:

LIFEMD, INC. 2023 ANNUAL REPORT
LifeMD, Inc. Board of Directors and Executive Officers as of April 29, 2024
BOARD OF DIRECTORS
Name
Principal Occupation or Employment
Justin Schreiber
Chairman of the Board of Directors, LifeMD, Inc.
Chief Executive Officer, LifeMD, Inc.
Partner, Strawn Pickens LLP
Clinical Professor of Surgery, New Jersey Medical School
Former Senior Director, Blackstone
Chief Financial Officer, Nostrella
Operating Adviser, Ares Private Equity Group
Senior Staff Physician, Boston Children   s Hospital
Chief Executive Officer and a Director, OptimizeRx Corporation
Vice Chair for Scientific Innovation at the Department of Medicine at
Brigham and Women   s Hospital and Associate Professor of Medicine at
Harvard Medical School
John R. Strawn, Jr.
Dr. Joseph V. DiTrolio, MD
Naveen Bhatia
Roberto Simon
Robert Jindal
Dr. Joan LaRovere, M.D.
William Febbo
'U  Calum MacRae, M.D., Ph.D.
EXECUTIVE OFFICERS
Name
Principal Occupation or Employment
Justin Schreiber
Stefan Galluppi
Marc Benathen
Nicholas Alvarez
Eric Yecies
Jessica Friedeman
Dennis Wijnker
Maria Stan
Shane Biffar
Chief Executive Officer
Chief Innovation Officer
Chief Financial Officer
Chief Acquisition Officer
Chief Legal Officer and General Counsel
Chief Marketing Officer
Chief Technology Officer
Controller and Chief Accounting Officer
Chief Compliance Officer and Deputy General Counsel



shareholder letter icon 4/29/2024 Letter Continued (Full PDF)
 

LFMD Stockholder/Shareholder Letter (LifeMD, Inc.) | www.StockholderLetter.com
Copyright © 2023 - 2024, All Rights Reserved

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.